ARTICLE | Clinical News
Aptocine talaporfin sodium: Phase II started
August 24, 2009 7:00 AM UTC
Light Sciences began a single-arm, open-label, Australian and New Zealand Phase II trial to evaluate 1 mg/kg IV Aptocine followed by 100 J/cm of light delivered for 83 minutes in 40 patients. ...